<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
---------
NATIONAL MEDICAL FINANCIAL SERVICES CORP
--------------------------------------------------------
(Name of Issuer)
COMMON STOCK
--------------------------------------------------------
(Title of Class of Securities)
636926 10 7
--------------------------------------------------------
(CUSIP Number)
MORRIS MAYBRUCH,
1 DANIELLECT, SUFFERN NY 10901
914 368-4800
--------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
January 9, 1998
--------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box / /.
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following page(s))
Page 1 of Pages
---
<PAGE>
CUSIP No. 636926107 13D Page 2 of Pages
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above
Persons
Morris Maybruch
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Source of Funds*
00 - Purchase price for sale of assets effective 1/1/98 between NMFS &
Morris Maybruch
- -------------------------------------------------------------------------------
(5) Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e)
- -------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
USA
- -------------------------------------------------------------------------------
Number of Shares (7) Sole Voting
Beneficially Owned Power 1,637,000
by Each Reporting --------------------------------------------------
Person With (8) Shared Voting
Power 1,637,000
--------------------------------------------------
(9) Sole Dispositive
Power 1,637,000
--------------------------------------------------
(10) Shared Dispositive
Power 1,637,000
- -------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
1,637,000
- -------------------------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
9.6%
- -------------------------------------------------------------------------------
(14) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Page 3 of Pages
--- ---
ITEM 1. SECURITY AND ISSUER
NATIONAL MEDICAL FINANCIAL SERVICES, COMMON STOCK
ITEM 2. IDENTITY AND BACKGROUND
MORRIS MAYBRUCH
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
PURCHASE PRICE FOR SALE OF ASSETS EFFECTIVE 1/1/98 BETWEEN
NMFS & MORRIS MAYBRUCH
ITEM 4. PURPOSE OF TRANSACTION
TRANSFER OF ASSETS AS PER ABOVE
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
9.6%
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
CONTRACT BETWEEN MAYBRUCH & NMFS FOR 1,637,000 SHARES OF RESTRICTED
COMMON STOCK FOR ASSETS.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
3; (2) the acquisition of issuer control, liquidation, sale of assets,
merger, or change in business or corporate structure or any other matter
as disclosed in Item 4; and (3) the transfer or voting of the
securities, finder's fees, joint ventures, options, puts, calls,
guarantees of loans, guarantees against loss of profit, or the giving or
withholding of any proxy as disclosed in Item 6.
<PAGE>
Page 4 of Pages
--- ---
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete
and correct.
1/16/98
----------------------------------------
(Date
/s/ Morris Maybruch
----------------------------------------
(Signature)
Morris Maybruch
----------------------------------------
(Name/Title)
